NUVL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $117,938,399.21

Nuvalent Insider Trading History Chart

Nuvalent Share Price & Price History

^$94.77

▼ -2.29 (-2.36%)

As of 03/20/2026 05:00 PM ET

Days: 30 | 90 | 365

Nuvalent Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/22/2026	Deborah Ann Miller	Insider	Sell	14,300	$110.16	$1,575,288.00	59,634
1/21/2026	Deborah Ann Miller	Insider	Sell	700	$109.84	$76,888.00	59,634
1/6/2026	Alexandra Balcom	CFO	Sell	3,181	$97.16	$309,065.96	81,733
1/6/2026	Christopher Durant Turner	Insider	Sell	3,181	$97.16	$309,065.96	55,130
1/6/2026	Deborah Ann Miller	Insider	Sell	2,589	$97.16	$251,547.24	42,134
1/6/2026	Henry E. Pelish	Insider	Sell	2,664	$97.17	$258,860.88	65,888
1/6/2026	James Richard Porter	CEO	Sell	9,543	$97.16	$927,197.88	278,629
1/5/2026	Alexandra Balcom	CFO	Sell	4,236	$97.32	$412,247.52	84,914
1/5/2026	Christopher Durant Turner	Insider	Sell	4,236	$97.32	$412,247.52	58,311
1/5/2026	Deborah Ann Miller	Insider	Sell	4,363	$97.32	$424,607.16	44,723
1/5/2026	Henry E. Pelish	Insider	Sell	2,496	$97.32	$242,910.72	68,552
1/5/2026	James Richard Porter	CEO	Sell	17,890	$97.32	$1,741,054.80	288,172
12/8/2025	Alexandra Balcom	CFO	Sell	7,084	$110.32	$781,506.88	54,650
11/24/2025	James E Flynn	Director	Sell	742,574	$95.44	$70,871,262.56	8,299,225
11/24/2025	Matthew Shair	Director	Sell	5,850	$109.37	$639,814.50	1,377,194
11/24/2025	Matthew Shair	Director	Sell	1,650	$109.37	$180,460.50	201,672
11/18/2025	Alexandra Balcom	CFO	Sell	729	$104.26	$76,005.54	61,734
11/17/2025	Alexandra Balcom	CFO	Sell	20,000	$99.45	$1,989,000.00	61,734
11/17/2025	Deborah Ann Miller	Insider	Sell	24,200	$105.50	$2,553,100.00	49,086
10/30/2025	Deborah Ann Miller	Insider	Sell	21,800	$103.16	$2,248,888.00	49,086
10/28/2025	Matthew Shair	Director	Sell	32,455	$100.27	$3,254,262.85	1,383,044
10/28/2025	Matthew Shair	Director	Sell	9,154	$100.27	$917,871.58	203,322
10/27/2025	Matthew Shair	Director	Sell	14,345	$100.23	$1,437,799.35	1,415,499
10/27/2025	Matthew Shair	Director	Sell	4,046	$100.23	$405,530.58	212,476
10/20/2025	Deborah Ann Miller	Insider	Sell	5,000	$94.91	$474,550.00	49,086
10/16/2025	Deborah Ann Miller	Insider	Sell	12,376	$91.66	$1,134,384.16	49,086
10/16/2025	James Richard Porter	CEO	Sell	27,000	$90.63	$2,447,010.00	249,062
10/15/2025	Alexandra Balcom	CFO	Sell	1,683	$85.57	$144,014.31	61,734
10/15/2025	Deborah Ann Miller	Insider	Sell	15,624	$89.98	$1,405,847.52	49,086
10/15/2025	Henry E. Pelish	Insider	Sell	14,205	$90.04	$1,279,018.20	65,963
10/14/2025	Henry E. Pelish	Insider	Sell	2,433	$85.78	$208,702.74	65,963
10/13/2025	Alexandra Balcom	CFO	Sell	20,000	$88.51	$1,770,200.00	61,734
10/13/2025	Henry E. Pelish	Insider	Sell	7,637	$89.81	$685,878.97	65,963
9/30/2025	Alexandra Balcom	CFO	Sell	20,000	$85.06	$1,701,200.00	61,734
9/29/2025	Alexandra Balcom	CFO	Sell	7,588	$85.01	$645,055.88	61,734
9/15/2025	James Richard Porter	CEO	Sell	27,000	$79.08	$2,135,160.00	249,062
9/10/2025	Henry E. Pelish	Insider	Sell	3,725	$78.83	$293,641.75	65,963
8/15/2025	James Richard Porter	CEO	Sell	27,000	$75.42	$2,036,340.00	249,062
8/7/2025	Henry E. Pelish	Insider	Sell	5,500	$74.85	$411,675.00	60,956
7/16/2025	Alexandra Balcom	CFO	Sell	14,700	$85.10	$1,250,970.00	61,734
7/15/2025	Alexandra Balcom	CFO	Sell	5,300	$83.50	$442,550.00	61,734
7/15/2025	James Richard Porter	CEO	Sell	27,000	$82.27	$2,221,290.00	249,062
7/10/2025	Henry E. Pelish	Insider	Sell	5,500	$79.98	$439,890.00	60,956
7/9/2025	Henry E. Pelish	Insider	Sell	2,145	$81.16	$174,088.20	60,956
6/27/2025	Alexandra Balcom	CFO	Sell	20,000	$80.02	$1,600,400.00	61,734
6/27/2025	Henry E. Pelish	Insider	Sell	2,170	$79.92	$173,426.40	63,101
6/25/2025	Henry E. Pelish	Insider	Sell	8,630	$79.87	$689,278.10	63,101
6/6/2025	Henry E. Pelish	Insider	Sell	200	$79.82	$15,964.00	63,101
4/15/2025	James Richard Porter	CEO	Sell	27,000	$68.94	$1,861,380.00	249,062
3/17/2025	James Richard Porter	CEO	Sell	27,000	$75.87	$2,048,490.00	249,062
2/24/2025	Matthew Shair	Director	Sell	2,000	$78.43	$156,860.00	216,522
2/18/2025	James Richard Porter	CEO	Sell	27,000	$78.46	$2,118,420.00	249,062
1/27/2025	Matthew Shair	Director	Sell	2,000	$82.79	$165,580.00	218,522
1/15/2025	James Richard Porter	CEO	Sell	27,000	$75.99	$2,051,730.00	249,062
1/6/2025	Alexandra Balcom	CFO	Sell	4,016	$79.68	$319,994.88	61,734
1/6/2025	Henry E. Pelish	Insider	Sell	2,483	$79.68	$197,845.44	59,981
1/6/2025	James Richard Porter	CEO	Sell	17,301	$79.68	$1,378,543.68	249,062
12/23/2024	Matthew Shair	Director	Sell	2,000	$83.78	$167,560.00	220,522
12/16/2024	James Richard Porter	CEO	Sell	27,000	$86.61	$2,338,470.00	188,113
11/25/2024	Matthew Shair	Director	Sell	2,000	$96.22	$192,440.00	222,522
10/31/2024	Alexandra Balcom	CFO	Sell	10,000	$89.19	$891,900.00	33,300
10/28/2024	Matthew Shair	Director	Sell	2,000	$91.73	$183,460.00	224,522
10/22/2024	James E Flynn	Director	Sell	2,000,000	$97.75	$195,500,000.00	8,670,512
10/15/2024	James Richard Porter	CEO	Sell	27,000	$102.28	$2,761,560.00	188,113
10/1/2024	Darlene Noci	Insider	Sell	5,000	$101.74	$508,700.00	33,300
9/30/2024	Alexandra Balcom	CFO	Sell	10,000	$101.06	$1,010,600.00	33,300
9/23/2024	Matthew Shair	Director	Sell	2,000	$102.75	$205,500.00	226,522
9/16/2024	Henry E. Pelish	Insider	Sell	32,795	$98.92	$3,244,081.40	33,300
9/9/2024	Deborah Ann Miller	Insider	Sell	3,000	$88.18	$264,540.00	33,300
9/3/2024	Darlene Noci	Insider	Sell	5,000	$84.43	$422,150.00	33,300
8/30/2024	Alexandra Balcom	CFO	Sell	10,000	$84.23	$842,300.00	33,300
8/26/2024	Matthew Shair	Director	Sell	2,000	$84.46	$168,920.00	228,522
8/23/2024	Emily Conley	Director	Sell	3,334	$85.02	$283,456.68	2,507
8/23/2024	Henry E. Pelish	Insider	Sell	10,500	$85.08	$893,340.00	66,095
8/8/2024	Deborah Ann Miller	Insider	Sell	3,000	$68.78	$206,340.00	33,300
8/1/2024	Darlene Noci	Insider	Sell	5,000	$77.22	$386,100.00	33,300
7/31/2024	Alexandra Balcom	CFO	Sell	10,000	$79.51	$795,100.00	33,300
7/29/2024	Matthew Shair	Director	Sell	2,000	$79.59	$159,180.00	230,522
7/15/2024	Emily Conley	Director	Sell	5,000	$80.72	$403,600.00	2,507
7/12/2024	Deborah Ann Miller	Insider	Sell	6,000	$80.16	$480,960.00	33,300
7/8/2024	Deborah Ann Miller	Insider	Sell	3,000	$73.23	$219,690.00	33,300
7/1/2024	Darlene Noci	Insider	Sell	5,000	$75.54	$377,700.00	33,300
6/28/2024	Alexandra Balcom	CFO	Sell	10,000	$75.43	$754,300.00	33,300
6/24/2024	Matthew Shair	Director	Sell	2,000	$80.22	$160,440.00	232,522
6/14/2024	Emily Conley	Director	Sell	5,000	$77.56	$387,800.00	2,507
5/28/2024	Matthew Shair	Director	Sell	2,000	$67.22	$134,440.00	234,522
5/13/2024	Matthew Shair	Director	Sell	37,500	$65.84	$2,469,000.00	1,424,698
5/6/2024	Matthew Shair	Director	Sell	37,500	$69.48	$2,605,500.00	1,462,198
5/2/2024	Deborah Ann Miller	Insider	Sell	3,000	$72.07	$216,210.00	33,300
4/29/2024	Matthew Shair	Director	Sell	2,000	$67.51	$135,020.00	236,522
4/22/2024	Matthew Shair	Director	Sell	37,500	$63.65	$2,386,875.00	1,537,198
4/15/2024	Matthew Shair	Director	Sell	37,500	$65.56	$2,458,500.00	1,574,698
4/8/2024	Matthew Shair	Director	Sell	37,500	$68.44	$2,566,500.00	1,612,198
4/4/2024	Deborah Ann Miller	Insider	Sell	3,000	$73.60	$220,800.00	33,300
4/1/2024	Matthew Shair	Director	Sell	37,500	$76.92	$2,884,500.00	1,649,698
3/28/2024	Deborah Ann Miller	Insider	Sell	22,000	$75.20	$1,654,400.00	33,300
3/27/2024	Andrew A.F. Hack	Director	Sell	880,000	$72.77	$64,037,600.00	2,697,267
3/25/2024	Matthew Shair	Director	Sell	37,500	$76.77	$2,878,875.00	1,687,198
3/22/2024	Darlene Noci	Insider	Sell	20,000	$77.51	$1,550,200.00	33,300
12/28/2023	Matthew Shair	Director	Sell	48,548	$75.46	$3,663,432.08	1,724,698
12/26/2023	Matthew Shair	Director	Sell	69,602	$75.12	$5,228,502.24	1,774,246
12/18/2023	Alexandra Balcom	CFO	Sell	30,000	$75.82	$2,274,600.00
12/18/2023	Anna Protopapas	Director	Sell	5,000	$75.67	$378,350.00
12/18/2023	Darlene Noci	insider	Sell	40,000	$75.82	$3,032,800.00
11/28/2023	Matthew Shair	Director	Sell	9,150	$61.89	$566,293.50	1,843,848
11/1/2023	Darlene Noci	insider	Sell	3,000	$52.66	$157,980.00
10/24/2023	Matthew Shair	Director	Sell	91,700	$50.70	$4,649,190.00	1,852,998
10/4/2023	Christopher Durant Turner	Insider	Sell	7,995	$54.04	$432,049.80	14,513
10/2/2023	Darlene Noci	insider	Sell	3,000	$45.88	$137,640.00
9/15/2023	Deborah Ann Miller	insider	Sell	2,000	$47.64	$95,280.00
9/1/2023	Darlene Noci	insider	Sell	3,000	$46.56	$139,680.00
8/1/2023	Darlene Noci	insider	Sell	3,000	$49.95	$149,850.00
7/28/2023	Christopher Durant Turner	Insider	Sell	2,665	$48.93	$130,398.45	14,513
7/26/2023	Christopher Durant Turner	Insider	Sell	2,365	$46.85	$110,800.25	14,513
7/24/2023	Christopher Durant Turner	Insider	Sell	200	$46.82	$9,364.00	14,513
7/19/2023	Darlene Noci	insider	Sell	4,559	$45.04	$205,337.36	14,513
7/17/2023	Deborah Ann Miller	insider	Sell	2,000	$43.06	$86,120.00
7/3/2023	Darlene Noci	insider	Sell	3,000	$41.48	$124,440.00
6/15/2023	Darlene Noci	insider	Sell	1,000	$45.07	$45,070.00
6/5/2023	Christopher Durant Turner	Insider	Sell	10,235	$44.86	$459,142.10	14,513
6/1/2023	Darlene Noci	insider	Sell	3,000	$42.64	$127,920.00
5/15/2023	Deborah Ann Miller	insider	Sell	2,000	$40.74	$81,480.00
5/9/2023	Deborah Ann Miller	insider	Sell	1,332	$39.63	$52,787.16
5/5/2023	Deborah Ann Miller	insider	Sell	2,800	$39.64	$110,992.00
5/1/2023	Darlene Noci	insider	Sell	3,000	$38.60	$115,800.00
4/17/2023	Deborah Ann Miller	insider	Sell	2,000	$30.10	$60,200.00
4/3/2023	Darlene Noci	insider	Sell	3,000	$26.59	$79,770.00

SEC Filings (Institutional Ownership Changes) for Nuvalent (NASDAQ:NUVL)

97.26% of Nuvalent stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nuvalent Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/20/2026	Hsbc Holdings PLC	6,948	$0.71M	0.0%	N/A	0.010%
2/26/2026	Seven Fleet Capital Management LP	12,601	$1.27M	1.0%	N/A	0.017%
2/19/2026	T. Rowe Price Investment Management Inc.	1,319,963	$132.78M	0.1%	+29.3%	1.815%
2/19/2026	Invesco Ltd.	439,300	$44.19M	0.0%	+1,201.4%	0.604%
2/18/2026	XTX Topco Ltd	15,498	$1.56M	0.0%	N/A	0.021%
2/18/2026	Ikarian Capital LLC	59,594	$6M	0.5%	N/A	0.082%
2/18/2026	Vestal Point Capital LP	46,000	$4.63M	0.2%	-95.8%	0.063%
2/18/2026	Virtus Investment Advisers LLC	2,538	$0.26M	0.1%	+73.7%	0.003%
2/18/2026	Wellington Management Group LLP	2,461,823	$247.64M	0.1%	+7.0%	3.386%
2/18/2026	Tang Capital Management LLC	21,880	$2.20M	0.1%	-56.2%	0.030%
2/18/2026	Perceptive Advisors LLC	1,665,105	$167.49M	3.0%	+6.6%	2.290%
2/18/2026	Millennium Management LLC	81,866	$8.24M	0.0%	N/A	0.113%
2/18/2026	Janus Henderson Group PLC	1,499,574	$150.82M	0.1%	-31.5%	2.062%
2/18/2026	Commodore Capital LP	550,000	$55.32M	3.7%	-60.7%	0.756%
2/18/2026	Artia Global Partners LP	8,100	$0.82M	0.1%	N/A	0.011%
2/18/2026	Boothbay Fund Management LLC	17,796	$1.79M	0.0%	N/A	0.024%
2/17/2026	Guggenheim Capital LLC	9,797	$0.99M	0.0%	-23.7%	0.013%
2/17/2026	ADAR1 Capital Management LLC	6,842	$0.69M	0.1%	-42.2%	0.009%
2/17/2026	Burkehill Global Management LP	70,000	$7.04M	0.5%	N/A	0.096%
2/17/2026	AQR Capital Management LLC	25,520	$2.57M	0.0%	-7.8%	0.035%
2/17/2026	Braidwell LP	821,406	$82.63M	2.6%	-18.9%	1.130%
2/17/2026	RA Capital Management L.P.	1,880,057	$189.12M	1.9%	+50.8%	2.586%
2/17/2026	ArrowMark Colorado Holdings LLC	296,029	$29.78M	0.7%	-18.4%	0.407%
2/17/2026	Jump Financial LLC	27,955	$2.81M	0.0%	+695.1%	0.038%
2/17/2026	Price T Rowe Associates Inc. MD	2,146,938	$215.96M	0.0%	+18.6%	2.953%
2/17/2026	T. Rowe Price Investment Management Inc.	368,774	$37.10M	0.0%	-63.9%	0.507%
2/17/2026	Adage Capital Partners GP L.L.C.	643,000	$64.68M	0.1%	+11.9%	0.884%
2/17/2026	California State Teachers Retirement System	38,284	$3.85M	0.0%	+1.1%	0.053%
2/17/2026	Russell Investments Group Ltd.	91,195	$9.17M	0.0%	-1.4%	0.125%
2/17/2026	Granahan Investment Management LLC	40,211	$4.05M	0.2%	N/A	0.055%
2/17/2026	State of Wisconsin Investment Board	25,197	$2.54M	0.0%	-11.8%	0.035%
2/17/2026	Fred Alger Management LLC	92,021	$9.26M	0.0%	+4.0%	0.127%
2/17/2026	Royal Bank of Canada	1,439	$0.15M	0.0%	-97.4%	0.002%
2/17/2026	Magnetar Financial LLC	4,254	$0.43M	0.0%	N/A	0.006%
2/17/2026	Polar Capital Holdings Plc	1,536,859	$154.59M	0.6%	+50.3%	2.114%
2/16/2026	Squarepoint Ops LLC	61,746	$6.21M	0.0%	+731.6%	0.085%
2/16/2026	Vanguard Personalized Indexing Management LLC	4,771	$0.48M	0.0%	+12.2%	0.007%
2/16/2026	Verition Fund Management LLC	72,015	$7.24M	0.0%	+1,163.0%	0.099%
2/16/2026	Mariner LLC	3,094	$0.31M	0.0%	N/A	0.004%
2/16/2026	Nicholas Investment Partners LP	160,483	$16.14M	1.2%	+29.2%	0.221%
2/16/2026	First Turn Management LLC	368,697	$37.09M	4.2%	-6.6%	0.507%
2/16/2026	Kennedy Capital Management LLC	10,932	$1.10M	0.0%	+1.5%	0.015%
2/16/2026	Entropy Technologies LP	6,586	$0.66M	0.0%	N/A	0.009%
2/16/2026	Barclays PLC	125,328	$12.61M	0.0%	-7.5%	0.172%
2/13/2026	FORA Capital LLC	2,171	$0.22M	0.0%	N/A	0.003%
2/13/2026	Marshall Wace LLP	23,930	$2.41M	0.0%	N/A	0.033%
2/13/2026	The Manufacturers Life Insurance Company	78,275	$7.86M	0.0%	+21.4%	0.108%
2/13/2026	Walleye Capital LLC	7,956	$0.80M	0.0%	+132.2%	0.011%
2/13/2026	Affinity Asset Advisors LLC	322,633	$32.45M	1.8%	-16.1%	0.444%
2/13/2026	Bridgewater Associates LP	18,578	$1.87M	0.0%	-15.8%	0.026%
2/13/2026	Rafferty Asset Management LLC	45,945	$4.62M	0.0%	-4.2%	0.063%
2/13/2026	First Trust Advisors LP	22,165	$2.23M	0.0%	N/A	0.030%
2/13/2026	Headlands Technologies LLC	9,225	$0.93M	0.1%	N/A	0.013%
2/13/2026	Alyeska Investment Group L.P.	25,533	$2.57M	0.0%	-74.7%	0.035%
2/13/2026	Charles Schwab Investment Management Inc.	453,311	$45.60M	0.0%	+12.1%	0.623%
2/13/2026	Police & Firemen s Retirement System of New Jersey	13,542	$1.36M	0.0%	+13.9%	0.019%
2/13/2026	State Street Corp	1,864,675	$187.57M	0.0%	+18.4%	2.565%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	124,555	$12.53M	0.0%	+90.4%	0.171%
2/13/2026	Wells Fargo & Company MN	62,155	$6.25M	0.0%	+101.3%	0.085%
2/13/2026	Lord Abbett & CO. LLC	281,215	$28.29M	0.1%	N/A	0.387%
2/13/2026	Rhenman & Partners Asset Management AB	163,350	$16.43M	1.5%	+211.1%	0.225%
2/12/2026	MetLife Investment Management LLC	27,631	$2.78M	0.0%	+10.1%	0.038%
2/12/2026	Cibc World Markets Corp	3,312	$0.33M	0.0%	N/A	0.005%
2/12/2026	Dimensional Fund Advisors LP	10,406	$1.05M	0.0%	-64.8%	0.014%
2/12/2026	Ensign Peak Advisors Inc	54,202	$5.45M	0.0%	-15.8%	0.075%
2/12/2026	AlphaCentric Advisors LLC	4,404	$0.44M	0.4%	N/A	0.006%
2/12/2026	New York State Common Retirement Fund	32,460	$3.27M	0.0%	+15.7%	0.045%
2/12/2026	Portland Investment Counsel Inc.	2,000	$0.20M	0.1%	N/A	0.003%
2/12/2026	Swiss National Bank	78,900	$7.94M	0.0%	+2.2%	0.109%
2/12/2026	Polen Capital Management LLC	6,359	$0.64M	0.0%	N/A	0.009%
2/12/2026	Nuveen LLC	107,620	$10.83M	0.0%	+17.4%	0.148%
2/12/2026	Xponance LLC	3,965	$0.40M	0.0%	+17.3%	0.005%
2/11/2026	Deutsche Bank AG	83,039	$8.35M	0.0%	+15.8%	0.114%
2/11/2026	LPL Financial LLC	2,539	$0.26M	0.0%	N/A	0.003%
2/11/2026	Franklin Resources Inc.	411,354	$41.38M	0.0%	+156.9%	0.566%
2/11/2026	JPMorgan Chase & Co.	2,205,251	$221.83M	0.0%	+32.9%	3.033%
2/10/2026	TD Asset Management Inc	153,360	$15.43M	0.0%	+39.9%	0.211%
2/10/2026	CIBC Asset Management Inc	2,495	$0.25M	0.0%	N/A	0.003%
2/10/2026	Goldman Sachs Group Inc.	594,459	$59.80M	0.0%	+33.8%	0.818%
2/10/2026	BNP Paribas Financial Markets	174,066	$17.51M	0.0%	+26.2%	0.239%
2/10/2026	Norges Bank	574,242	$57.76M	0.0%	N/A	0.790%
2/10/2026	Intech Investment Management LLC	17,184	$1.73M	0.0%	+14.9%	0.024%
2/10/2026	Seven Grand Managers LLC	25,000	$2.52M	0.2%	N/A	0.034%
2/9/2026	Geode Capital Management LLC	1,238,234	$124.58M	0.0%	+13.2%	1.703%
2/9/2026	Fisher Asset Management LLC	100,706	$10.13M	0.0%	-5.4%	0.139%
2/9/2026	Legal & General Group Plc	41,651	$4.19M	0.0%	-3.8%	0.057%
2/6/2026	Legato Capital Management LLC	21,732	$2.19M	0.2%	+71.8%	0.030%
2/6/2026	PSP Research LLC	5,261	$0.53M	0.5%	N/A	0.007%
2/6/2026	Profund Advisors LLC	17,536	$1.76M	0.1%	+64.1%	0.024%
2/6/2026	ProShare Advisors LLC	12,318	$1.24M	0.0%	+26.7%	0.017%
2/4/2026	Swiss Life Asset Management Ltd	2,009	$0.20M	0.0%	N/A	0.003%
2/2/2026	Strs Ohio	11,700	$1.18M	0.0%	+44.4%	0.016%
1/30/2026	State of New Jersey Common Pension Fund D	13,653	$1.37M	0.0%	-52.7%	0.019%
1/29/2026	Comerica Bank	20,224	$2.03M	0.0%	+25,180.0%	0.028%
1/29/2026	Pictet Asset Management Holding SA	355,681	$35.78M	0.0%	-7.5%	0.489%
1/29/2026	UBS Group AG	399,053	$40.14M	0.0%	+87.2%	0.549%
1/29/2026	Teachers Retirement System of The State of Kentucky	11,761	$1.18M	0.0%	+8.4%	0.016%
1/29/2026	Vanguard Group Inc.	5,244,271	$527.52M	0.0%	+13.9%	7.213%
1/29/2026	NBC Securities Inc.	1,247	$0.13M	0.0%	N/A	0.002%
1/28/2026	Arizona State Retirement System	11,176	$1.12M	0.0%	-5.1%	0.015%

Data available starting January 2016

Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the phase 2 portion of the ALKOVE-1 Phase 1/2 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR, which is expected to initiate phase 1 trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $94.77

$94.43

$98.70

50 Day Range

MA: $102.53

$94.77

$111.99

52 Week Range

Now: $94.77

$55.53

$113.01

Volume

951,777 shs

Average Volume

522,486 shs

Market Capitalization

$6.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Nuvalent?: Nuvalent's top insider shareholders include:
James E Flynn (Director)
Andrew A F Hack (Director)
Matthew Shair (Director)
James Richard Porter (CEO)
Alexandra Balcom (CFO)
Henry E Pelish (Insider)
Deborah Ann Miller (Insider)
Christopher Durant Turner (Insider)
Darlene Noci (Insider)
Emily Conley (Director)
Learn More about top insider investors at Nuvalent.
Who are the major institutional investors of Nuvalent?: Nuvalent's top institutional shareholders include:
Vanguard Group Inc. — 7.21%
Wellington Management Group LLP — 3.39%
JPMorgan Chase & Co. — 3.03%
Price T Rowe Associates Inc. MD — 2.95%
RA Capital Management L.P. — 2.59%
State Street Corp — 2.56%
Learn More about top institutional investors of Nuvalent stock.
Which institutional investors are selling Nuvalent stock?: Within the previous quarter, NUVL stock was sold by these institutional investors:
Vestal Point Capital LP
Commodore Capital LP
Janus Henderson Group PLC
T. Rowe Price Investment Management Inc.
Braidwell LP
Alyeska Investment Group L.P.
ArrowMark Colorado Holdings LLC
Affinity Asset Advisors LLC
In the previous year, company insiders that have sold Nuvalent company stock include:
James E Flynn (Director)
Andrew A F Hack (Director)
Matthew Shair (Director)
James Richard Porter (CEO)
Alexandra Balcom (CFO)
Henry E Pelish (Insider)
Deborah Ann Miller (Insider)
Learn More investors selling Nuvalent stock.
Which institutional investors are buying Nuvalent stock?: In the previous quarter, NUVL stock was acquired by institutional investors including:
Vanguard Group Inc.
RA Capital Management L.P.
Norges Bank
JPMorgan Chase & Co.
Polar Capital Holdings Plc
Invesco Ltd.
Price T Rowe Associates Inc. MD
T. Rowe Price Investment Management Inc.